Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease

doi:10.3748/wjg.v25.i18.2177

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10714)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-7) series, Tables (1-1) series.

Item

Count

PDF

546

WORD

268

HTML

5676

Figures (1-7)

334

Tables (1-1)

231

Sum=7055

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

638

Download

645

Sum=1283

Publishing Process of This Article

Item

Count

Browse

1088

Download

1288

Sum=2376

May 14, 2019 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. May 14, 2019; 25(18): 2177-2187
Published online May 14, 2019. doi: 10.3748/wjg.v25.i18.2177

Full Size Figure Download Figure

Figure 6 Positive and negative effects of CRISPR when targeting gene ATG16L1. UC: Ulcerative colitis; CRC: Colorectal cancer.

Citation: Limanskiy V, Vyas A, Chaturvedi LS, Vyas D. Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease. World J Gastroenterol 2019; 25(18): 2177-2187
URL: https://www.wjgnet.com/1007-9327/full/v25/i18/2177.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i18.2177